It reduces relapse rates and slows down disease progression.
Finlim 0.5 mg is a disease-modifying therapy (dmt) used in the treatment of relapsing-remitting multiple sclerosis (rrms) in adults and children aged 10 years and older. It reduces relapse rates and slows down disease progression.